#United States #Chicago #Shapiro+Raj #Lisa La Brooy #Pharma Insights

Lisa La Brooy Elevated to President of Shapiro+Raj

On July 15, 2026, Shapiro+Raj, a leading consultancy in strategic insights for the life sciences sector, announced the promotion of Lisa La Brooy to the position of President. This strategic decision comes at a time when the firm is accelerating its growth significantly, outpacing competitors in the insights category. With deepening partnerships in the pharmaceutical and biotech fields, La Brooy is set to guide the organization’s strategic vision and deliver excellence.

Lisa La Brooy possesses over 20 years of experience in client-facing roles, particularly within the life sciences sector. Her impressive track record has established her as a reliable strategic partner for organizations grappling with complex commercial and clinical decisions. At Shapiro+Raj, she has fostered a culture where senior leaders engage directly with clients and project teams, ensuring a collaborative working environment that drives results.

As the newly appointed President, La Brooy will focus on the firm’s strategic growth agenda, talent development, and delivery excellence. Her hands-on leadership style will allow her to remain closely connected with clients and project teams, a characteristic that Zain Raj, Chairman and CEO, emphasizes as critical to the firm's success. Raj commented, “Life sciences companies are moving faster than ever, and the leadership quality is key for accelerating products to market.”

Notably, La Brooy's promotion comes as Shapiro+Raj continues to innovate and differentiate itself in a competitive landscape. The firm has adopted a unique approach that integrates human expertise with AI technologies, setting it apart from traditional consultancies. La Brooy's appointment is seen as pivotal for sustaining and extending this momentum, particularly with regard to client partnerships and operational strategies.

Amir Kapadia, who serves as President of Stella - Shapiro+Raj's proprietary AI agent business, will continue to handle the firm's operations. Their combined efforts will forge a powerful leadership team poised to navigate the complexities of the life sciences market while maintaining focus on client needs.

Originally from Australia, La Brooy’s journey took her across various industries before she narrowed her focus to pharmaceutical insights. Her move to the U.S. was motivated by a desire to face new challenges and grow professionally. She reflects on her career path, stating, “I took a risk moving across the world because I wanted to be challenged. Shapiro+Raj became that place for me.”

Looking ahead, La Brooy is committed to ensuring that Shapiro+Raj remains a place of growth, innovation, and client commitment. “My responsibility is to help ensure it remains that kind of place for our people and our clients as we grow,” she expressed. “I intend to stay deeply involved in the work while helping scale the intellectual curiosity and strategic courage that brought us here.”

Shapiro+Raj has earned a reputation as a top-tier strategic insights consultancy, recognized for its innovative spirit. By integrating behavioral science with AI, the firm aims to expedite the introduction of pharmaceuticals to the market. La Brooy’s leadership is poised to further this mission, solidifying Shapiro+Raj’s position within the industry.

Together, Raj and La Brooy represent the vision and capability needed to advance Shapiro+Raj's legacy and future, as they navigate the evolving landscape of life sciences insights. Their partnership exemplifies a commitment to innovation, excellence, and strategic growth in a competitive market.